These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28387887)

  • 21. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as therapeutic options in the treatment of renal cancer: A meta-analysis.
    Asgharzadeh F; Hashemzehi M; Moradi-Marjaneh R; Hassanian SM; Ferns GA; Khazaei M; Avan A
    Life Sci; 2020 Feb; 242():117181. PubMed ID: 31863771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.
    Qin Y; Chen T; Chen Q; Lv JY; Qi N; Wu C; He J
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):503-11. PubMed ID: 26786323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W; Zheng F; Song X; Zhong B; Yan L
    Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.
    Yuge K; Miyajima A; Tanaka N; Shirotake S; Kosaka T; Kikuchi E; Oya M
    Ann Surg Oncol; 2012 Nov; 19(12):3987-93. PubMed ID: 22872290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of renin-angiotensin system blockade on graft survival and cardiovascular disease in kidney transplant recipients: retrospective multicenter study in Japan.
    Tsuchimoto A; Masutani K; Ueki K; Nakagawa K; Matsukuma Y; Tanaka S; Unagami K; Kakuta Y; Okumi M; Noguchi H; Kaku K; Okabe Y; Nakano T; Kitazono T; Nakamura M; Ishida H; Tanabe K;
    Clin Exp Nephrol; 2020 Apr; 24(4):369-378. PubMed ID: 31875930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
    Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
    Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin system-targeting antihypertensive drugs and risk of vascular cognitive impairment: A meta-analysis.
    Zhuang S; Li J; Wang X; Wang HF; Zhang WJ; Wang HY; Xing CM
    Neurosci Lett; 2016 Feb; 615():1-8. PubMed ID: 26797651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer.
    Zeman M; Skałba W; Wilk AM; Cortez AJ; Maciejewski A; Czarniecka A
    BMC Cancer; 2022 Jul; 22(1):815. PubMed ID: 35879682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
    Bracci S; Valeriani M; Agolli L; De Sanctis V; Maurizi Enrici R; Osti MF
    Clin Lung Cancer; 2016 May; 17(3):189-97. PubMed ID: 26427647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
    Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
    Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Zhang Y; Zhang P; Mu Y; Gao M; Wang JR; Wang Y; Su LQ; Hou YL
    Clin Pharmacol Ther; 2010 Oct; 88(4):521-31. PubMed ID: 20811347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.
    Farcas A; Leucuta D; Bucsa C; Mogosan C; Dumitrascu D
    Int J Clin Pharm; 2016 Dec; 38(6):1390-1397. PubMed ID: 27677980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
    Hoang V; Alam M; Addison D; Macedo F; Virani S; Birnbaum Y
    Cardiovasc Drugs Ther; 2016 Apr; 30(2):189-98. PubMed ID: 26861251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blockers of renin-angiotensin-aldosterone system in the treatment of arterial hypertension: classics versus the modern].
    Kanorskiĭ SG
    Kardiologiia; 2013; 53(10):89-95. PubMed ID: 24645559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
    Shih CJ; Chu H; Ou SM; Chen YT
    Int J Cardiol; 2015 Nov; 199():283-9. PubMed ID: 26218587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which patients should be on renin-angiotensin system blockers after coronary surgery?
    Alassar A; Bazerbashi S; Easto R; Unsworth-White J
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):667-72. PubMed ID: 24997188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
    Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination.
    Bomback AS; Toto R
    Am J Hypertens; 2009 Oct; 22(10):1032-40. PubMed ID: 19661925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy?
    Kim ST; Park KH; Oh SC; Seo JH; Kim JS; Shin SW; Kim YH
    Oncology; 2012; 83(6):354-60. PubMed ID: 23052034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.